| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |